“…Principally, in the presence of aqueous ions and other charged species, polyplexes tend to aggregate with themselves or other biomolecules such as serum proteins, which severely limits the targeting potential of polyplexes to specific tissues when delivered through the circulatory systems of whole animals. ,, For example, polyplexes formed with PEI become trapped in the lungs during first-pass circulation due to aggregation upon systemic injection. , Moreover, PEI polyplexes also suffer from rapid clearance from the blood by the reticuloendothelial system due to nonspecific charge-mediated interactions with serum proteins. , To prevent these detrimental interactions, polyethylene glycol (PEG) is commonly used as a hydrophilic outer layer to sterically stabilize polyplexes from aggregation and prolong circulation times by reducing nonspecific interactions with the reticuloendothelial system. , However, PEG has a limited effect on polyplex stability and undergoes accelerated blood clearance after multiple injections. , Several other structures have been explored as alternatives to PEG to achieve colloidal stability and biocompatibility. These include zwitterionic structures like polysulfobetaine, biodegradable polymers such as poly(2-hydroxyethyl methacrylate) and poly(lactic- co -glycolic acid). − Earlier work from our lab has demonstrated that diblock polymers containing glucose or trehalose-substituted monomers copolymerized with a cationic block form colloidally stable polyplexes and offer potential as alternative hydrophilic coating layers. ,− These sugar-derived neutral blocks form a “stealth” layer that prevents aggregation while maintaining excellent gene-delivery properties in cultured cells. , …”